Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2003
04/08/2003CA2205015C Method for producing biologicals in protein-free culture
04/08/2003CA2184584C Vascular endothelial growth factor 2
04/08/2003CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
04/08/2003CA2107732C Retrovirus from the hiv group and its use
04/08/2003CA2103829C Peg-interferon conjugates
04/08/2003CA2006332C Method of detecting neurological disease or dysfunction
04/04/2003WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
04/04/2003CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
04/03/2003WO2003027316A2 Methods of using 33751, a human potassium channel family member
04/03/2003WO2003027291A2 Hdv nucleic acid molecules, fragments and applications thereof
04/03/2003WO2003027287A1 Kidney-specific urate transporter and gene thereof
04/03/2003WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027254A2 15625 receptor, a novel g-protein coupled receptor
04/03/2003WO2003027248A2 Antibody inhibitors of gdf-8 and uses thereof
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027169A1 Material consisting of at least a biodegradable polymer and cyclodextrins
04/03/2003WO2003027151A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003WO2003027143A2 Gene and protein relating to hepatocellular carcinoma
04/03/2003WO2003026705A1 Methods for sterilizing biological materials using flavonoid/flavonol stabilizers
04/03/2003WO2003026704A1 Methods of sterilizing biological mixtures using stabilizer mixtures
04/03/2003WO2003026703A1 Methods of sterilizing biological materials containing non-aqueous solvents
04/03/2003WO2003026692A2 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex
04/03/2003WO2003026691A2 Use of hmgb1 for the activation of dendritic cells
04/03/2003WO2003026690A1 Incapacitated whole-cell immunogenic bacterial compositions
04/03/2003WO2003026689A1 Autologous growth factor cocktail composition, method of production and use
04/03/2003WO2003026688A1 Biphasic liposomes containing immunogen and cpg, for stimulating an immune response
04/03/2003WO2003026674A1 Coadministration of transport protein with conjugated cobalamin to deliver agents
04/03/2003WO2003026579A2 Combination therapies for immune mediated diseases
04/03/2003WO2003026578A2 Pine cone extracts and uses thereof
04/03/2003WO2003026528A1 Method and tools for oral hygiene
04/03/2003WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
04/03/2003WO2003026479A2 Methods of suppressing microglial activation
04/03/2003WO2003006104A3 Lymphatic endothelial cells materials and methods
04/03/2003WO2003002722A3 T cell regulatory genes and methods of use thereof
04/03/2003WO2002102305A3 Adjuvant composition for mucosal and injection delivered vaccines
04/03/2003WO2002100317A3 Targeted particles and methods of using the same
04/03/2003WO2002099052A3 Opns as modifiers of the p53 pathway and methods of use
04/03/2003WO2002099051A3 Nits as modifiers of the p53 pathway and methods of use
04/03/2003WO2002098359A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
04/03/2003WO2002092016A3 Therapeutic use of rank antagonists
04/03/2003WO2002088336A3 Genetically modified yt cell line and use thereof
04/03/2003WO2002073213A3 Assay
04/03/2003WO2002072836A3 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES
04/03/2003WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/03/2003WO2002044419A3 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/03/2003WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
04/03/2003WO2002009748A9 Innate immune system-directed vaccines
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003US20030065362 Method for genetic immunization
04/03/2003US20030065158 Propagation of cattle respiratory syncytial virus; propagate cells, insert synthetic nucleotide sequences codiing phosphoprotein into cell, mutate transfered nucleotide sequences, monitor gene expression
04/03/2003US20030065151 Secreted protein HCEJQ69
04/03/2003US20030065145 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
04/03/2003US20030065142 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
04/03/2003US20030065137 Immunological methods to modulate myostatin in vertebrate subjects
04/03/2003US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents
04/03/2003US20030064984 Anticancer agents; side effect reduction
04/03/2003US20030064947 Polypeptides; induction immunology response; cancer diagnosis
04/03/2003US20030064925 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064916 Antigen peptides; medical diagnosis
04/03/2003US20030064510 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
04/03/2003US20030064477 Novel E6 targeted protein (E6TP1)
04/03/2003US20030064439 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia and alzheimer's diseases
04/03/2003US20030064418 Protein for use in the diagnosis and treatment of cancer
04/03/2003US20030064413 Compositions and methods useful in avidity therapy
04/03/2003US20030064408 Protein-protein interactions
04/03/2003US20030064407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064385 Genes expressed in breast cancer as prognostic and therapeutic targets
04/03/2003US20030064378 Compositions and methods relating to lung specific genes and proteins
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064361 Preparing viral vaccine; obtain glycoprotein, determine neutralizing epitope, generate vaccine associated with neutralizing epitope
04/03/2003US20030064360 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
04/03/2003US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion
04/03/2003US20030064080 Administering hapten modified syngeneic human tumor cell substantially in a no growth phase and an adjuvant for therapy of cancer
04/03/2003US20030064079 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
04/03/2003US20030064078 Vaccines
04/03/2003US20030064077 Recombinant poxvirus cytomegalovirus, compositions, and uses
04/03/2003US20030064075 For diagnosis, therapy and prophylaxis of malaria; vaccines
04/03/2003US20030064074 Recombinant gelatins in vaccines
04/03/2003US20030064073 Active immunization using a siderophore receptor protein
04/03/2003US20030064072 For diagnosis, therapy and prophylaxis of disorders related to the lung, including lung cancer
04/03/2003US20030064071 Method of using a facilitator of retroviral entry into cells
04/03/2003US20030064069 Specific binding members for TGFbeta1
04/03/2003US20030064068 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
04/03/2003US20030064067 Inducing differentiation and/or promoting proliferation of regulatory T cells, comprising allowing a CD3 agonist and a 4C8 antigen agonist to act on an immunocyte expressing CD3 and 4C8 antigens
04/03/2003US20030064065 35 kappaD tumor associated protein antigen: uses and methods detection
04/03/2003US20030064064 Administering formulation that inhibits activity of IgE(immunoglobulin E) sufficient to decrease the activity of IgE and administering to the subject second formulation amount of the antigen sufficient to modulate the immune response
04/03/2003US20030064062 For use in pharmaceuticals, diagnostics, biosensors and bioreactors
04/03/2003US20030064058 Methods of utilizing bone marrow stem cells for inducing immunological tolerance
04/03/2003US20030064054 Detection of human immunodeficiency virus using cells transduced with a complex viral vector
04/03/2003US20030064052 Useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery
04/03/2003US20030064032 Process for nebulizing aqueous compositions containing highly concentrated insulin
04/03/2003US20030064000 Methods of sterilizing biological mixtures using stabilizer mixtures
04/03/2003CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003CA2469230A1 Antibody inhibitors of gdf-8 and uses thereof
1 ... 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 ... 1823